ZICX:OTO-Zicix Corporation (USD)

COMMON STOCK | Software - Application | OTC Pink

Last Closing

USD 0.0011

Change

+0.00 (+10.00)%

Market Cap

USD 0.02B

Volume

0.13M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Zicix Corp provides medical diagnostic services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Software - Application

Symbol Name Price(Change) Market Cap
SAPGF SAP SE

-1.65 (-0.74%)

USD 259.28B
CNSWF Constellation Software Inc

-31.21 (-0.97%)

USD 66.90B
WTCHF WiseTech Global Limited

+14.57 (+19.71%)

USD 29.48B
DIDIY Didi Global Inc ADR

-0.02 (-0.51%)

USD 18.88B
XROLF Xero Limited

-0.49 (-0.51%)

USD 14.70B
SGGEF The Sage Group plc

N/A

USD 13.50B
NEMKY Nemetschek SE

N/A

USD 11.31B
LMGIF Lumine Group Inc.

+0.63 (+2.51%)

USD 6.66B
TMSNY Temenos Group AG ADR

+0.45 (+0.64%)

USD 5.28B
FNOXF Fortnox AB (publ)

N/A

USD 4.37B

ETFs Containing ZICX

ETP:CA First Trust Global Risk M.. 4.08 % 0.98 %

-0.05 (0.00%)

CAD 0.01B
ZMU:CA BMO Mid-Term US IG Corpor.. 0.00 % 0.27 %

N/A

CAD 2.97B

Market Performance

  Market Performance vs. Industry/Classification (Software - Application) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.22% 71% C- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.22% 71% C- 73% C
Trailing 12 Months  
Capital Gain 37.50% 73% C 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.50% 73% C 80% B-
Trailing 5 Years  
Capital Gain -91.41% 39% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -91.41% 39% F 19% F
Average Annual (5 Year Horizon)  
Capital Gain -32.26% 13% F 7% C-
Dividend Return -32.26% 13% F 7% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 51.91% 64% D 49% F
Risk Adjusted Return -62.15% 16% F 12% F
Market Capitalization 0.02B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative earnings

The company had negative total earnings in the most recent four quarters.